As FDA misses deadline on electric shock ban, disability advocates speak out
-
By
-
O. Rose Broderick
-
June 1, 2026
-
Clinical Scorecard: Disability Advocates Raise Concerns as FDA Misses Deadline on Electric Shock Device Regulation
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | |
| Care Setting | Judge Rotenberg Center, Massachusetts, known for controversial use of electrical shock devices. |
Key Highlights
- FDA missed its deadline to decide on banning electrical shock devices, originally set for May 2023.
- The practice is criticized as a form of torture by UN officials and the American Academy of Pediatrics, with ongoing legal challenges since 2013.
Guideline-Based Recommendations
Diagnosis
- Consider DSM-5 criteria for self-injurious behavior.
Management
- Behavioral treatments should be prioritized over electrical shock devices, with evidence-based practices recommended.
Monitoring & Follow-up
Risks
- Potential for PTSD and fear in individuals subjected to shock therapy, with long-term psychological impacts.
Patient & Prescribing Data
Treatment effectiveness is debated, with claims of behavior change being linked to fear rather than actual improvement; further studies are needed.
Clinical Best Practices
- Consider alternative behavioral therapies before resorting to shock devices, ensuring they are evidence-based.
- Ensure informed consent from families and legal guardians before treatment, including a thorough explanation of risks and benefits.
Related Resources & Content
